Description: Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Home Page: www.tjpcty.com
No. 19, Xinye 9th Street
Tianjin,
300462
China
Phone:
86 22 6527 7560
Officers
| Name | Title |
|---|---|
| Mr. Xin Liu | GM & Director |
| Ms. Xiuchun Zheng | Financial Director |
| Mr. Lifeng Wang | Deputy GM & Director |
| Ms. Shuli Wang | Chief Engineer |
| Ms. Wang Chunli | Board Sec. |
| Mr. Sheng Wu | Deputy Gen. Mang. |
| Ms. Xiaoyun Jiang | Vice Gen. Mang. |
| Mr. Kewen Liu | Vice Gen. Mang. |
| Yu Feng Yao | Deputy Gen. Mang. |
| Yaoming Liu | Deputy Gen. Mang. |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 108.75 |
| Price-to-Book MRQ: | 1.7571 |
| Price-to-Sales TTM: | 1.4137 |
| IPO Date: | 2001-05-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 2635 |